The University of Nebraska-Lincoln, in partnership with the University of Nebraska Medical Center, proposes to establish the Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules (NPOD) as a Center of Biomedical Research Excellence. NPOD will unite research strengths in nutrient signaling to develop junior faculty talent and utilize novel approaches in discovery-based research and translation to combat the growing epidemic of obesity-related disorders through consumer friendly and cost-efficient intervention strategies, beginning with a focus on cardiovascular disease, diabetes, and non-alcoholic fatty liver disease. NPOD will create a nationally recognized center charged with developing and sustaining a critical mass of investigators dedicated to obesity research and leverage Center discoveries to devise and implement effective strategies for the prevention of obesity-related diseases through the dietary manipulation of nutrient signaling pathways. The Center's goals will be accomplished through three specific aims to: (1) establish an administrative core and programs to support and enhance NPOD research;(2) develop a critical mass of faculty through the support of five thematically linked primary research projects, a vigorous mentoring program for Project Leaders, a pilot grant program, a Molecular Biology, Bioinformatics and Biostatistics Core facility, and a research tool development program in the Core;and (3) increase research capacity through targeted recruitment of researchers in areas key to Center success. NPOD's world-class, multidisciplinary research environment will be instrumental in supporting the development of strategies to prevent cardiovascular disease, diabetes, and non-alcoholic fatty liver disease;creating a skilled workforce in a national priority area;implementing techniques fo translating discoveries in the laboratory to inform clinical practice and influence consumer behavior;and utilizing innovative approaches to instant sharing of research data and dissemination of recommendations for consumers. NPOD investigators bring the breadth of expertise necessary to accomplish the Center's grand vision and share the common tenant that obesity-related diseases can be prevented through the manipulation of nutrient signaling pathways and that this prevention strategy is attractive and accessible to consumers, thus holding great potential for long-term national impact.

Public Health Relevance

Preventing obesity-related diseases through use of dietary compounds has strong potential to improve human health through strategies that are user-friendly, non-invasive, and cost effective. NPOD, which is governed by the hypothesis that building a critical mass of well-mentored investigators will yield important gains in the preventio of obesity diseases through dietary molecules, is expected to make significant and lasting contributions to the health and well-being of United States citizens.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM104320-01A1
Application #
8624887
Study Section
Special Emphasis Panel (ZGM1-TWD-C (C1))
Program Officer
Liu, Yanping
Project Start
2014-08-05
Project End
2019-05-31
Budget Start
2014-08-05
Budget End
2015-05-31
Support Year
1
Fiscal Year
2014
Total Cost
$2,516,001
Indirect Cost
$680,648
Name
University of Nebraska Lincoln
Department
Miscellaneous
Type
Schools of Education
DUNS #
555456995
City
Lincoln
State
NE
Country
United States
Zip Code
68583
Kim, Jiyoung; Okla, Meshail; Erickson, Anjeza et al. (2016) Eicosapentaenoic Acid Potentiates Brown Thermogenesis through FFAR4-dependent Up-regulation of miR-30b and miR-378. J Biol Chem 291:20551-62
Wang, Hai; Zhao, Miaoyun; Sud, Neetu et al. (2016) Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis. Sci Rep 6:32246
Lu, Sizhao; Natarajan, Sathish Kumar; Mott, Justin L et al. (2016) Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway. PLoS One 11:e0147474
Farris, Eric; Brown, Deborah M; Ramer-Tait, Amanda E et al. (2016) Micro- and nanoparticulates for DNA vaccine delivery. Exp Biol Med (Maywood) 241:919-29
Krumbeck, Janina A; Maldonado-Gomez, Maria X; Ramer-Tait, Amanda E et al. (2016) Prebiotics and synbiotics: dietary strategies for improving gut health. Curr Opin Gastroenterol 32:110-9
Cordonier, Elizabeth L; Jarecke, Sarah K; Hollinger, Frances E et al. (2016) Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells. Eur J Pharmacol 780:202-8
Yang, Junyi; Bindels, Laure B; Segura Munoz, Rafael R et al. (2016) Disparate Metabolic Responses in Mice Fed a High-Fat Diet Supplemented with Maize-Derived Non-Digestible Feruloylated Oligo- and Polysaccharides Are Linked to Changes in the Gut Microbiota. PLoS One 11:e0146144
Xie, Fang; Anderson, Christopher L; Timme, Kelsey R et al. (2016) Obesity-Dependent Increases in Oocyte mRNAs Are Associated With Increases in Proinflammatory Signaling and Gut Microbial Abundance of Lachnospiraceae in Female Mice. Endocrinology 157:1630-43
Natarajan, Sathish Kumar; Rasineni, Karuna; Ganesan, Murali et al. (2015) Structure, function and metabolism of hepatic and adipose tissue lipid droplets: implications in alcoholic liver disease. Curr Mol Pharmacol :
Shu, Jiang; Chiang, Kevin; Zempleni, Janos et al. (2015) Computational Characterization of Exogenous MicroRNAs that Can Be Transferred into Human Circulation. PLoS One 10:e0140587

Showing the most recent 10 out of 24 publications